Cargando…
A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C
BACKGROUND: Production of human monoclonal antibodies that exhibit broadly neutralizing activity is needed for preventing HIV-1 infection, however only a few such antibodies have been generated till date. Isolation of antibodies by the hybridoma technology is a cumbersome process with fewer yields....
Autores principales: | Kumar, Rajesh, Andrabi, Raiees, Tiwari, Ashutosh, Prakash, Somi Sankaran, Wig, Naveet, Dutta, Durgashree, Sankhyan, Anurag, Khan, Lubina, Sinha, Subrata, Luthra, Kalpana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536577/ https://www.ncbi.nlm.nih.gov/pubmed/23153214 http://dx.doi.org/10.1186/1472-6750-12-87 |
Ejemplares similares
-
Production and expression of recombinant anti-V3 scFvs from HIV-1 clade C infected Indian patient
por: Kumar, Rajesh, et al.
Publicado: (2012) -
Generation and characterization of human monoclonal single chain variable fragments (scFvs) against envelope third variable region (V3) of HIV-1 clade C
por: Kumar, Rajesh, et al.
Publicado: (2012) -
Construction of site selected phage library and characterization of anti-V3 scFvs from Indian clade C HIV-1 infected patient
por: Kumar, R, et al.
Publicado: (2012) -
Chicken scFvs with an Artificial Cysteine for Site-Directed Conjugation
por: Yoon, Aerin, et al.
Publicado: (2016) -
Directed evolution of human scFvs in DT40 cells
por: Lim, Alfred W.Y., et al.
Publicado: (2016)